Golden
Elcelyx Therapeutics

Elcelyx Therapeutics

A company that develops products for weight management and obesity-related metabolic disorders

Elcelyx Therapeutics is a biotechnology company developing products for weight management and obesity-related metabolic disorders that is headquartered in San Diego, California and was founded in 2010 by Alain D. Baron. 

Funding

Series A

On March 17, 2010 Elcelyx Therapeutics completed their series A funding round with $1.2 million in funding from undisclosed investors. 

Series B

On August 13, 2012 Elcelyx Therapeutics completed their series B funding round with $4 million in funding from Morgenthaler Ventures, Kleiner Perkins Caufield & Byers, and Technology Partners. 

Series C

On February 24, 2014 Elcelyx Therapeutics completed their series C funding round with $20 million in funding from Technology Partners, Morgenthaler Ventures, Kleiner Perkins, and GMS Fund. 

Series D

On February 23, 2015 Elcelyx Therapeutics completed their series D funding round with $5.8 million in funding from undisclosed investors. 

Series E

On October 5, 2015 Elcelyx Therapeutics completed their series E funding round with $40 million in funding from Sailing Capital (lead investor), Clough Capital Partners, Morgenthaler Ventures, Kleiner Perkins Caufield & Byers, Technology Partners, and GSM Fund. 

Timeline

Funding rounds

3 Results
Funding round
Funding round
Funded company
Funded company
Funding round amount (USD)
Funding round amount (USD)
Funding type
Funding type
Funding round date
Funding round date
Investment
Investment

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References